ワシントンにおける小細胞肺がんの臨床試験
ワシントン内の拠点で、小細胞肺がんに関する13件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Northwest Medical Specialties, Tacoma
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Fred Hutchinson Cancer Research Center, Seattle
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/09/22更新 · NCT07006727Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- University of Washington Fred Hutchinson, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
- Fred Hutchinson Cancer Center, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT07564401A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- Swedish Cancer Institute - Edmonds, Edmonds
- Swedish Medical Center, Seattle
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06646276AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Seattle
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Fred Hutch Cancer Research, Seattle
被験者募集中第1/2相
18歳〜100歳 · 全性別 · 2026/08/27更新 · NCT06726148A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Northwest Cancer Specialists, Vancouver
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06095505A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Fred Hutch Cancer Center, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT05652686A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Swedish Cancer Institute, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07174583Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- Swedish Cancer Institute, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/26更新 · NCT06598306A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 105, Spokane
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。